You are here :
Home
Healthcare Market Research Reports
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
European Implantable Drug Delivery Devices Market The European Implantable Drug Delivery Market is mainly driven by growing prevalence of target disease segments such as Prostate Cancer, diabetic retinopathy, chronic pain causing diseases, cardiovascular diseases, Colorectal Cancer, and a rapid aging global population.The Market was Valued at $2.5 billion in 2013 and expected to be $3.2 billion by 2018, growing at a CAGR of 5.3 %. The Implantable Drug Delivery Market analyzes the market by segments such as Drug eluting stents, Infusion Pumps, Intraocular Implants, Brachytherapy Seeds, Contraceptive Implants.The prominent players in the Market are Boston Scientific, Abbott Laboratories, Medtronic, Allergen INC, Merck, Bayer Pharma AG, Arrow International, Theragenics, Varian Medical Systems, and Eckert Ziegler. |
Upcoming |
|
|
Asian Implantable Drug Delivery Devices Market The Asian Implantable Drug Delivery Market is mainly driven by growing prevalence of target disease segments such as Prostate Cancer, diabetic retinopathy, chronic pain causing diseases, cardiovascular diseases, Colorectal Cancer, and a rapid aging global population.The Market was Valued at $1.6 billion in 2013 and expected to be $2.4 billion by 2018, growing at a CAGR of 8.8%. The Implantable Drug Delivery Market analyzes the market by segments such as Drug eluting stents, Infusion Pumps, Intraocular Implants, Brachytherapy Seeds, Contraceptive Implants.The prominent players in the Market are Boston Scientific, Abbott Laboratories, Medtronic, Allergen INC, Merck, Bayer Pharma AG, Arrow International, Theragenics, Varian Medical Systems, and Eckert Ziegler. |
Upcoming |
|
|
North American Injectables Drug Delivery devices Market The North American Injectable Drug Delivery Devices Market is mainly driven by growing prevalence of target disease segments such as diabetes, multiple sclerosis, Crohn’s disease, rheumatoid arthritis, psoriasis, reproductive diseases and cancer. The Market was Valued at $4.6 billion in 2013 and expected to be $7.2 billion by 2018, growing at a CAGR of 9.2%. The Injectable Drug Delivery Devices Market analyzes the market by segments such as Conventional injectable devices, Self injection devices, other injectable devices.The prominent players in the Market are Becton Dickinson and Co., Terumo Corporation, Baxter International Inc., Antares Pharma Inc., West Pharmaceutical Services Inc., Haselmeier GmbH, Ypsomed Holding AG, and Nova Nordisk A/S. |
Upcoming |
|
|
European Injectables Drug Delivery devices Market The European Injectable Drug Delivery Devices Market is mainly driven by growing prevalence of target disease segments such as diabetes, multiple sclerosis, Crohn’s disease, rheumatoid arthritis, psoriasis, reproductive diseases and cancer. The Market was Valued at $3.9 billion in 2013 and expected to be $6.7 billion by 2018, growing at a CAGR of 11.1%. The Injectable Drug Delivery Devices Market analyzes the market by segments such as Conventional injectable devices, Self injection devices, other injectable devices.The prominent players in the Market are Becton Dickinson and Co., Terumo Corporation, Baxter International Inc., Antares Pharma Inc., West Pharmaceutical Services Inc., Haselmeier GmbH, Ypsomed Holding AG, and Nova Nordisk A/S. |
Upcoming |
|
|
Asian Injectables Drug Delivery devices Market The Asian Injectable Drug Delivery Devices Market is mainly driven by growing prevalence of target disease segments such as diabetes, multiple sclerosis, Crohn’s disease, rheumatoid arthritis, psoriasis, reproductive diseases and cancer. The Market was Valued at $2.1 billion in 2013 and expected to be $4.1 billion by 2018, growing at a CAGR of 14.4%. The Injectable Drug Delivery Devices Market analyzes the market by segments such as Conventional injectable devices, Self injection devices, other injectable devices.The prominent players in the Market are Becton Dickinson and Co., Terumo Corporation, Baxter International Inc., Antares Pharma Inc., West Pharmaceutical Services Inc., Haselmeier GmbH, Ypsomed Holding AG, and Nova Nordisk A/S. |
Upcoming |
|
|
Asia Conventional Injectable Drug delivery Devices Conventional Injectable Drug delivery Devices-Asia market has been pegged at 0.0m in the year 2013 growing at annually and is projected to reach 0.0m by the end of the year 2018. It is segmented on basis of . What makes our report unique?... |
Upcoming |
|
|
North American Natural Biomaterials Market The report “The North American Natural Biomaterials market forecast 2012-2018” analyzes the market by technology devices into 5 segments such as Alginate, Hyaluronic Acid, Collagen & Gelatin, Chitin and Cellulose. Some of the key players in The North American Natural Biomaterials market include Medtronic, Inc., Biomet, Inc., Stryker Corporation, Synthes, Inc. and others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
|
|
Asian Natural Biomaterials Market The report “The Asian Natural Biomaterials market forecast 2012-2018” analyzes the market by technology devices into 5 segments such as Alginate, Hyaluronic Acid, Collagen & Gelatin, Chitin and Cellulose. Some of the key players in The Asian Natural Biomaterials market include Medtronic, Inc., Biomet, Inc., Stryker Corporation, Synthes, Inc. and others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
|
|
European Natural Biomaterials Market The report “The European Natural Biomaterials market forecast 2012-2018” analyzes the market by technology devices into 5 segments such as Alginate, Hyaluronic Acid, Collagen & Gelatin, Chitin and Cellulose. Some of the key players in The European Natural Biomaterials market include Medtronic, Inc., Biomet, Inc., Stryker Corporation, Synthes, Inc. and others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
|
|
Asian Absorbable Sutures The Asian absorbable sutures market is driven by aging population, rising incidence of chronic disease, and increasing use of sutures in child delivery process to repair episiotomy and tears at childbirth. The market value was $80 million in 2013 and estimated to be $93 million by 2018, at a CAGR of 3.3%.The Asian absorbable sutures market can be segmented on the basis of geography, companies and macroindicator.Deep dive analysis of the top players of this market have been considered in this report. |
Upcoming |
|
|
European Absorbable Sutures The European absorbable sutures market is driven by aging population, rising incidence of chronic disease, and increasing use of sutures in child delivery process to repair episiotomy and tears at childbirth. The market value was $128 million in 2013 and estimated to be $136 million by 2018, at a CAGR of 1.3%.The European absorbable sutures market can be segmented on the basis of geography, companies and macroindicator.Deep dive analysis of the top players of this market have been considered in this report. |
Upcoming |
|
|
North American Absorbable Sutures The North American absorbable sutures market is driven by aging population, rising incidence of chronic disease, and increasing use of sutures in child delivery process to repair episiotomy and tears at childbirth. The market value was $388 million in 2013 and estimated to be $421 million by 2018, at a CAGR of 1.8%. The North American absorbable sutures market can be segmented on the basis of geography, companies and macroindicator.Deep dive analysis of the top players of this market have been considered in this report. |
Upcoming |
|
|
North American Non-absorbable The North American non-absorbable sutures market is driven by aging population, rising incidence of chronic diseases, and surgeries. The market value was $ 317 million in 2013 and is estimated to be $342 million by 2018, at a CAGR of 1.7%. The report “North American Non-Absorbable Sutures Market Forecast, 2012-2018”, analyzes the market of non-absorbable sutures in terms of materials such as surgical silk, surgical cotton, linen and synthetic non-absorbable polymers. The key players of the market covered in this report are Smith & Nephew, 3M healthcare, Johnson and Johnson, Derma Sciences, Covidien, Molnlycke healthcare, and others. |
Upcoming |
|
|
Asian Non-absorbable mArket Research Report The Asian non-absorbable sutures market is driven by aging population, rising incidence of chronic diseases, and surgeries. The market value was $ 65 million in 2013 and is estimated to be $48 million by 2018, at a CAGR of 3.2%. The report “Asian Non-Absorbable Sutures Market Forecast, 2012-2018”, analyzes the market of non-absorbable sutures in terms of materials such as surgical silk, surgical cotton, linen and synthetic non-absorbable polymers. |
Upcoming |
|
|
European Non-absorbable market research report The European non-absorbable sutures market is driven by aging population, rising incidence of chronic diseases, and surgeries. The market value was $ 105 million in 2013 and is estimated to be $ 110 million by 2018, at a CAGR of 1.3%. The report “European Non-Absorbable Sutures Market Forecast, 2012-2018”, analyzes the market of non-absorbable sutures in terms of materials such as surgical silk, surgical cotton, linen and synthetic non-absorbable polymers. The key players of the market covered in this report are Smith & Nephew, Johnson and Johnson, Derma Sciences, Covidien, Molnlycke healthcare, and others. |
Upcoming |
|
|
Asian Cardiovascular Biomaterials Market The report “The Asian Cardiovascular Biomaterials market forecast 2012-2018” analyzes the market by technology devices into 8 segments such as Catheters, Guide wires, Sensor, Pacemaker, Implantable Cardiac Defibrillators, Vascular Grafts, Heart Valves and Stents. Some of the key players in The Asian Cardiovascular Biomaterials market include Medtronic, Inc., Biomet, Inc., Stryker Corporation, Synthes, Inc. and others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
|
|
North American Cardiovascular Biomaterials Market The report “The North American Cardiovascular Biomaterials market forecast 2012-2018” analyzes the market by technology devices into 8 segments such as Catheters, Guide wires, Sensor, Pacemaker, Implantable Cardiac Defibrillators, Vascular Grafts, Heart Valves and Stents. Some of the key players in The North American Cardiovascular Biomaterials market include Medtronic, Inc., Biomet, Inc., Stryker Corporation, Synthes, Inc. and others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
|
|
European Cardiovascular Biomaterials Market The report “The European Cardiovascular Biomaterials market forecast 2012-2018” analyzes the market by technology devices into 8 segments such as Catheters, Guide wires, Sensor, Pacemaker, Implantable Cardiac Defibrillators, Vascular Grafts, Heart Valves and Stents. Some of the key players in The European Cardiovascular Biomaterials market include Medtronic, Inc., Biomet, Inc., Stryker Corporation, Synthes, Inc. and others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
|
|
Asian Opthalmic Biomaterials Market The report “The Asian Opthalmic Biomaterials market forecast 2012-2018” analyzes the market by technology devices into 5 segments such as Intraoccular lenses, Contact lenses, Functional replacement of Occular tissues, Synthetic Corneas and Others. Some of the key players in The Asian Opthalmic Biomaterials market include S&V Technologies, Rayner., InVision Biomedical. and others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
|
|
European Opthalmic Biomaterials Market The report “The European Opthalmic Biomaterials market forecast 2012-2018” analyzes the market by technology devices into 5 segments such as Intraoccular lenses, Contact lenses, Functional replacement of Occular tissues, Synthetic Corneas and Others. Some of the key players in The European Opthalmic Biomaterials market include S&V Technologies, Rayner., InVision Biomedical. and others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
Healthcare
